Kellerman S E, Tokars J I, Jarvis W R
Hospital Infections Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Infect Control Hosp Epidemiol. 1998 Sep;19(9):629-34. doi: 10.1086/647888.
We studied hospital costs associated with healthcare worker (HCW) respiratory protection and respirator fit-testing programs recommended by the Centers for Disease Control and Prevention (CDC) and mandated by the Occupational Safety and Health Administration to decrease nosocomial or occupational Mycobacterium tuberculosis (TB).
The number and cost of high-efficiency particulate air (HEPA)-filter and dust-mist (DM) respirators for 1989 to 1994 were obtained from study hospital purchasing departments, and the costs of HCW fit-testing and education programs for 1994 were estimated from information provided by infection control practitioners. Costs of N-class respirator programs were estimated for study hospitals using retrospective cost analysis and an observational study.
Four urban hospitals with, and one rural community hospital without, documented nosocomial or occupational transmission of multidrug-resistant TB.
During the study period, four of five hospitals introduced HEPA and DM respirators and respirator education and fit-testing programs. Median costs in 1994 were $83,900 (range, $2,000-$223,000) for respirators and $17,187 (range, $8,736-$26,175) for respiratory fit-testing programs. The projected median annual cost of N95 respirators was $62,023 (range, $270-$422,526).
Compliance with CDC TB guidelines may require a substantial investment. However, outlays for respirators and education and fit-testing programs are more reasonable than would be suggested by analyses that estimated the costs of preventing one case of nosocomial TB.
我们研究了与医护人员(HCW)呼吸防护及呼吸器适配性测试项目相关的医院成本,这些项目是由疾病控制与预防中心(CDC)推荐并由职业安全与健康管理局强制实施的,旨在减少医院内或职业性结核分枝杆菌(TB)感染。
1989年至1994年高效空气微粒(HEPA)过滤器和防尘雾(DM)呼吸器的数量及成本从研究医院采购部门获取,1994年医护人员适配性测试及教育项目的成本根据感染控制从业人员提供的信息估算。使用回顾性成本分析和观察性研究估算研究医院N类呼吸器项目的成本。
四家有记录显示存在耐多药结核医院内或职业传播的城市医院,以及一家无此记录的农村社区医院。
在研究期间,五家医院中有四家引入了HEPA和DM呼吸器以及呼吸器教育和适配性测试项目。1994年呼吸器的中位数成本为83,900美元(范围:2,000美元至223,000美元),呼吸适配性测试项目的中位数成本为17,187美元(范围:8,736美元至26,175美元)。N95呼吸器预计的年度中位数成本为62,023美元(范围:270美元至422,526美元)。
遵守CDC结核病指南可能需要大量投资。然而,与呼吸器、教育及适配性测试项目相关的支出比那些估算预防一例医院内结核病成本的分析所显示的更为合理。